CLN.WA
Celon Pharma S.A. [CLN.WA] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CLN.WA Stock Summary
Top 10 Correlated ETFs
CLN.WA
Top 10 Correlated Stocks
CLN.WA
In the News
CLN.WA Financial details
Company Rating
-
Market Cap
765.85M
Income
-19.13M
Revenue
167.89M
Book val./share
-
Cash/share
-
Dividend
0.09
Dividend %
0.57%
Employees
513
Optionable
No
Shortable
Yes
Earnings
26 Apr 2024
P/E
-43.29
Forward P/E
-
PEG
-9.02
P/S
4.8
P/B
1.8
P/C
-
P/FCF
-26.11
Quick Ratio
1.44
Current Ratio
1.74
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.37
EPS next Y
-
EPS next Q
-
EPS this Y
208%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
5.27%
Revenue Q/Q
0.64%
EPS Q/Q
-172.22%
-
-
-
-
SMA20
-6.19%
SMA50
6.71%
SMA100
-5.78%
Inst Own
-
Inst Trans
-
ROA
-3%
ROE
-4%
ROC
-0.03%
Gross Margin
60%
Oper. Margin
-9%
Profit Margin
-11%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
13.1-17.94
52W High
+51.47%
52W Low
+98.08%
RSI
51.57
Rel Volume
2.17
Avg Volume
14.34K
Volume
31.06K
Perf Week
7.07%
Perf Month
-6.02%
Perf Quarter
-5.85%
Perf Half Y
-9.01%
-
-
-
-
Beta
0.799
-
-
Volatility
0.41%, 1.15%
Prev Close
-3.38%
Price
25.75
Change
-0.96%
CLN.WA Financial Performance
CLN.WA Frequently Asked Questions
What is Celon Pharma S.A. stock symbol ?
Celon Pharma S.A. is a PL stock and trading under the symbol CLN.WA
What is Celon Pharma S.A. stock quote today ?
Celon Pharma S.A. stock price is $25.75 today.
Is Celon Pharma S.A. stock public?
Yes, Celon Pharma S.A. is a publicly traded company.
Company Profile
- Volume Average 14.34K
- Market Capitalization 765.85M
- Employee 513
- CEO Dr. Maciej Wieczorek Ph.D.
- Headquarters lomianki,PL
- IPO Date 2017-02-17
-
Website
https://www.celonpharma.com 
Celon Pharma S.A., an integrated pharmaceutical company, researches, manufactures, and markets pharmaceutical products and preparations. The company operates through Generic Drug and Innovative segments. It offers drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. The company was founded in 2002 and is based in Lomianki, Poland. Celon Pharma S.A. is a subsidiary of Glatton Sp. z o.o.
